When a California company that’s developing a medicine to treat opioid addiction went looking for new office and lab space, it went across the country to West Virginia, which leads the U.S. in fatal drug overdose deaths.

Irvine-based GATC Health Corp., a drug discovery company that uses artificial intelligence in medicine discovery, is leasing more than 7,000 square feet of lab and office space at the sprawling West Virginia University Innovation Corp. center in Morgantown. Last year, the university took ownership of the 1.1 million-square-foot former Mylan Pharmaceuticals manufacturing plant and GATC is among the building’s three new science and technology tenants.

“If we can pull this off, we can help a lot of people,” GATC Chief Operating Officer Tyrone Lam said. “We’re looking for partners for human trials.”

GATC is working on drugs to treat post-traumatic stress disorder and fentanyl addiction, using AI to narrow down the number of compounds that are likely to be effective. The company, which was founded in 2020 and employs about 35 people, uses a mathematical system, called a neural network, to mimic human physiology and identify treatments for disease much faster than conventional research.

Advertise with us

GATC’s opioid addiction treatment reduces substance abuse and the chances of relapse while easing withdrawal symptoms. Mr. Lam said that testing of the medicine has begun in animals at the University of California, Irvine.

Two other pharmaceutical companies recently joined GATC in moving to the innovation center — Yunigen LLC, which has corporate offices in Pasadena, Calif., and leased 25,000 square feet, and Morgantown-based ExesaLibero Pharma Inc., which took 1,034 square feet for lab space.

“The laboratory facilities at the WVUIC are ideal for the continuation of the work we started on the WVU Health Sciences campus,” ExesaLibero President and Chief Scientific Officer John Barnett said in a prepared statement. “We are looking forward to moving into these facilities.”

Mr. Barnett is also a professor and chair of the WVU School of Medicine Department of Microbiology, Immunology and Cell Biology.

Mylan merged with Pfizer Inc.’s Upjohn unit to form Viatris in 2020 and the closing of the Morgantown plant was part of the new company’s cost-cutting strategy. The Morgantown plant closed in July 2021, eliminating 1,400 jobs. West Virginia University purchased the plant in March 2022 for $1 for redevelopment as a home for startups and other businesses.

Kris B. Mamula: kmamula@post-gazette.com